rs144914894
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP2BP4_StrongBP6_Very_StrongBS2
The NM_181303.2(NLGN3):āc.1954A>Gā(p.Thr652Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00383 in 1,210,181 control chromosomes in the GnomAD database, including 10 homozygotes. There are 1,432 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_181303.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NLGN3 | NM_181303.2 | c.1954A>G | p.Thr652Ala | missense_variant | 8/8 | ENST00000358741.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NLGN3 | ENST00000358741.4 | c.1954A>G | p.Thr652Ala | missense_variant | 8/8 | 5 | NM_181303.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00201 AC: 225AN: 111982Hom.: 0 Cov.: 22 AF XY: 0.00164 AC XY: 56AN XY: 34134
GnomAD3 exomes AF: 0.00226 AC: 413AN: 182497Hom.: 2 AF XY: 0.00222 AC XY: 149AN XY: 67089
GnomAD4 exome AF: 0.00401 AC: 4408AN: 1098145Hom.: 10 Cov.: 32 AF XY: 0.00379 AC XY: 1376AN XY: 363503
GnomAD4 genome AF: 0.00201 AC: 225AN: 112036Hom.: 0 Cov.: 22 AF XY: 0.00164 AC XY: 56AN XY: 34198
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 04, 2014 | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 03, 2017 | - - |
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Aug 01, 2018 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 24, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at